Hyun W. Bae, MD

Dr. Bae is a national leader in minimally invasive surgery, motion preservation technology, artificial disc replacement, and non-fusion technologies. As a leading researcher in stem cell repair of degenerative disc disease and the use of growth factors to treat spinal cord injury, he has been published extensively in top journals and presented at many national and international meetings. 

Dr. Bae was among the first to use growth factor tissue engineering for intervertebral discs, multi-level artificial disc replacement for both the lumbar and cervical spine, and other novel medical devices for dynamic stabilization and minimally invasive spine surgery.

Dr. Bae earned a bachelor’s degree in biomechanics from the Columbia University School of Engineering and Applied Sciences. He earned his medical degree, cum laude, from the Yale University School of Medicine. He completed his surgical internship at North Shore University Hospital and his orthopaedic surgical residency at the Hospital for Special Surgery in New York. He completed a spine fellowship at Case Western Reserve Hospital in Cleveland.

He then went on to earn his medical degree, cum laude, at Yale University School of Medicine. Dr. Bae completed his surgical internship at North Shore University Hospital and his orthopaedic surgical residency at the Hospital for Special Surgery in New York. He completed his spine fellowship at Case Western Hospital in Cleveland.

Dr. Bae has written numerous articles based on his research as well as presenting on behalf of the American Academy of Orthopaedic Surgery. He is researching the use of adult stem cells in the regeneration of nervous tissue in spinal cord injuries.

Dr. Bae has been the inventor of many patents and has been a successful entrepreneur in the field of medical devices. He is the cofounder or Prosidyan the leader in synthetic bone graft substitutes in the field of spine and orthopaedic surgery. After leading the company to a projected 40 million annual sales, the company was acquired by Johnson and Johnson in 2022. He is also the cofounder of Engage Surgical which developed the first cement less partial knee replacement approved for use in the US. The company was acquired by Smith and Nephew in 2022.